{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:21:17Z","timestamp":1792905677427,"version":"4.5.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:00:00Z","timestamp":1649030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genom Data"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The coronavirus nonstructural protein 5 (Nsp5) is a cysteine protease required for processing the viral polyprotein and is therefore crucial for viral replication. Nsp5 from several coronaviruses have also been found to cleave host proteins, disrupting molecular pathways involved in innate immunity. Nsp5 from the recently emerged SARS-CoV-2 virus interacts with and can cleave human proteins, which may be relevant to the pathogenesis of COVID-19. Based on the continuing global pandemic, and emerging understanding of coronavirus Nsp5-human protein interactions, we set out to predict what human proteins are cleaved by the coronavirus Nsp5 protease using a bioinformatics approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Using a previously developed neural network trained on coronavirus Nsp5 cleavage sites (NetCorona), we made predictions of Nsp5 cleavage sites in all human proteins. Structures of human proteins in the Protein Data Bank containing a predicted Nsp5 cleavage site were then examined, generating a list of 92 human proteins with a highly predicted and accessible cleavage site. Of those, 48 are expected to be found in the same cellular compartment as Nsp5. Analysis of this targeted list of proteins revealed molecular pathways susceptible to Nsp5 cleavage and therefore relevant to coronavirus infection, including pathways involved in mRNA processing, cytokine response, cytoskeleton organization, and apoptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study combines predictions of Nsp5 cleavage sites in human proteins with protein structure information and protein network analysis. We predicted cleavage sites in proteins recently shown to be cleaved in vitro by SARS-CoV-2 Nsp5, and we discuss how other potentially cleaved proteins may be relevant to coronavirus mediated immune dysregulation. The data presented here will assist in the design of more targeted experiments, to determine the role of coronavirus Nsp5 cleavage of host proteins, which is relevant to understanding the molecular pathology of coronavirus infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12863-022-01044-y","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:02:53Z","timestamp":1649034173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Predicted coronavirus Nsp5 protease cleavage sites in the human proteome"],"prefix":"10.1186","volume":"23","author":[{"given":"Benjamin M.","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Lacasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ditte G.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Tonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaj S.","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,4]]},"reference":[{"issue":"4","key":"1044_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","volume":"26","author":"KG Andersen","year":"2020","unstructured":"Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450\u20132.","journal-title":"Nat Med"},{"issue":"11","key":"1044_CR2","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/j.cub.2020.05.023","volume":"30","author":"H Zhou","year":"2020","unstructured":"Zhou H, Chen X, Hu T, Li J, Song H, Liu Y, et al. A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1\/S2 cleavage site of the spike protein. Curr Biol. 2020;30(11):2196\u2013203 e3.","journal-title":"Curr Biol"},{"issue":"5","key":"1044_CR3","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(20)30129-8","volume":"20","author":"A Wilder-Smith","year":"2020","unstructured":"Wilder-Smith A, Chiew CJ, Lee VJ. Can we contain the COVID-19 outbreak with the same measures as for SARS? Lancet Infect Dis. 2020;20(5):e102\u2013e7.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"1044_CR4","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","volume":"20","author":"E Petersen","year":"2020","unstructured":"Petersen E, Koopmans M, Go U, Hamer DH, Petrosillo N, Castelli F, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. 2020;20(9):e238\u2013e44.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"1044_CR5","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475\u201381.","journal-title":"Lancet Respir Med"},{"key":"1044_CR6","doi-asserted-by":"crossref","unstructured":"Robba C, Battaglini D, Pelosi P, Rocco PRM. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2. Expert rev. Respir Med. 2020;14(9):865-8.","DOI":"10.1080\/17476348.2020.1778470"},{"key":"1044_CR7","doi-asserted-by":"crossref","unstructured":"Puelles VG, Lutgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020.","DOI":"10.1056\/NEJMc2011400"},{"issue":"6","key":"1044_CR8","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089\u201398.","journal-title":"Intensive Care Med"},{"issue":"5","key":"1044_CR9","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/liv.14435","volume":"40","author":"L Xu","year":"2020","unstructured":"Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40(5):998\u20131004.","journal-title":"Liver Int"},{"issue":"1","key":"1044_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/ane.13266","volume":"142","author":"A Whittaker","year":"2020","unstructured":"Whittaker A, Anson M, Harky A. Neurological manifestations of COVID-19: a systematic review and current update. Acta Neurol Scand. 2020;142(1):14\u201322.","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"1044_CR11","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.chom.2020.04.009","volume":"27","author":"EJ Giamarellos-Bourboulis","year":"2020","unstructured":"Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. Complex immune Dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27(6):992\u20131000 e3.","journal-title":"Cell Host Microbe"},{"issue":"7821","key":"1044_CR12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584(7821):463\u20139.","journal-title":"Nature."},{"issue":"49","key":"1044_CR13","doi-asserted-by":"publisher","first-page":"eabd7114","DOI":"10.1126\/sciimmunol.abd7114","volume":"5","author":"L Kuri-Cervantes","year":"2020","unstructured":"Kuri-Cervantes L, Pampena MB, Meng W, Rosenfeld AM, Ittner CAG, Weisman AR, et al. Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci Immunol. 2020;5(49):eabd7114.","journal-title":"Sci Immunol"},{"issue":"6508","key":"1044_CR14","doi-asserted-by":"publisher","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","volume":"369","author":"D Mathew","year":"2020","unstructured":"Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508):eabc8511.","journal-title":"Science."},{"issue":"37","key":"1044_CR15","doi-asserted-by":"publisher","first-page":"12910","DOI":"10.1074\/jbc.REV120.013930","volume":"295","author":"E Hartenian","year":"2020","unstructured":"Hartenian E, Nandakumar D, Lari A, Ly M, Tucker JM, Glaunsinger BA. The molecular virology of coronaviruses. J Biol Chem. 2020;295(37):12910\u201334.","journal-title":"J Biol Chem"},{"issue":"Pt 4","key":"1044_CR16","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1099\/0022-1317-81-4-853","volume":"81","author":"J Ziebuhr","year":"2000","unstructured":"Ziebuhr J, Snijder EJ, Gorbalenya AE. Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol. 2000;81(Pt 4):853\u201379.","journal-title":"J Gen Virol."},{"issue":"11","key":"1044_CR17","doi-asserted-by":"publisher","first-page":"e27228","DOI":"10.1371\/journal.pone.0027228","volume":"6","author":"CP Chuck","year":"2011","unstructured":"Chuck CP, Chow HF, Wan DC, Wong KB. Profiling of substrate specificities of 3C-like proteases from group 1, 2a, 2b, and 3 coronaviruses. PLoS One. 2011;6(11):e27228.","journal-title":"PLoS One"},{"issue":"17","key":"1044_CR18","doi-asserted-by":"publisher","first-page":"127377","DOI":"10.1016\/j.bmcl.2020.127377","volume":"30","author":"S Ullrich","year":"2020","unstructured":"Ullrich S, Nitsche C. The SARS-CoV-2 main protease as drug target. Bioorg Med Chem Lett. 2020;30(17):127377.","journal-title":"Bioorg Med Chem Lett"},{"key":"1044_CR19","doi-asserted-by":"publisher","first-page":"n2713","DOI":"10.1136\/bmj.n2713","volume":"375","author":"E Mahase","year":"2021","unstructured":"Mahase E. Covid-19: Pfizer\u2019s paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ. 2021;375:n2713.","journal-title":"BMJ."},{"issue":"Pt 3","key":"1044_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1099\/0022-1317-83-3-595","volume":"83","author":"A Hegyi","year":"2002","unstructured":"Hegyi A, Ziebuhr J. Conservation of substrate specificities among coronavirus main proteases. J Gen Virol. 2002;83(Pt 3):595\u20139.","journal-title":"J Gen Virol"},{"issue":"32","key":"1044_CR21","doi-asserted-by":"publisher","first-page":"19403","DOI":"10.1074\/jbc.M115.651463","volume":"290","author":"S Tomar","year":"2015","unstructured":"Tomar S, Johnston ML, St John SE, Osswald HL, Nyalapatla PR, Paul LN, et al. Ligand-induced dimerization of Middle East respiratory syndrome (MERS) coronavirus nsp5 protease (3CLpro): implications for nsp5 regulation and the development of antivirals. J Biol Chem. 2015;290(32):19403\u201322.","journal-title":"J Biol Chem"},{"issue":"9","key":"1044_CR22","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1111\/febs.12222","volume":"280","author":"T Muramatsu","year":"2013","unstructured":"Muramatsu T, Kim YT, Nishii W, Terada T, Shirouzu M, Yokoyama S. Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins. FEBS J. 2013;280(9):2002\u201313.","journal-title":"FEBS J"},{"issue":"6489","key":"1044_CR23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.abb3405","volume":"368","author":"L Zhang","year":"2020","unstructured":"Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science. 2020;368(6489):409\u201312.","journal-title":"Science."},{"issue":"7811","key":"1044_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, et al. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582(7811):289\u201393.","journal-title":"Nature."},{"issue":"3","key":"1044_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s10930-020-09901-4","volume":"39","author":"FK Yoshimoto","year":"2020","unstructured":"Yoshimoto FK. The proteins of severe acute respiratory syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19. Protein J. 2020;39(3):198\u2013216.","journal-title":"Protein J"},{"issue":"2","key":"1044_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41589-020-00689-z","volume":"17","author":"W Rut","year":"2021","unstructured":"Rut W, Groborz K, Zhang L, Sun X, Zmudzinski M, Pawlik B, et al. SARS-CoV-2 M(pro) inhibitors and activity-based probes for patient-sample imaging. Nat Chem Biol. 2021;17(2):222\u20138.","journal-title":"Nat Chem Biol"},{"issue":"4","key":"1044_CR27","doi-asserted-by":"publisher","first-page":"e00524","DOI":"10.1128\/mBio.00524-13","volume":"4","author":"MM Angelini","year":"2013","unstructured":"Angelini MM, Akhlaghpour M, Neuman BW, Buchmeier MJ. Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. mBio. 2013;4(4):e00524\u201313.","journal-title":"mBio."},{"issue":"6509","key":"1044_CR28","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1126\/science.abd3629","volume":"369","author":"G Wolff","year":"2020","unstructured":"Wolff G, Limpens R, Zevenhoven-Dobbe JC, Laugks U, Zheng S, de Jong AWM, et al. A molecular pore spans the double membrane of the coronavirus replication organelle. Science. 2020;369(6509):1395\u20138.","journal-title":"Science."},{"issue":"3","key":"1044_CR29","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","volume":"2","author":"AL Totura","year":"2012","unstructured":"Totura AL, Baric RS. SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr Opin Virol. 2012;2(3):264\u201375.","journal-title":"Curr Opin Virol"},{"issue":"20","key":"1044_CR30","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1002\/1873-3468.12827","volume":"591","author":"J Lei","year":"2017","unstructured":"Lei J, Hilgenfeld R. RNA-virus proteases counteracting host innate immunity. FEBS Lett. 2017;591(20):3190\u2013210.","journal-title":"FEBS Lett"},{"key":"1044_CR31","first-page":"1","volume":"419","author":"AH de Wilde","year":"2018","unstructured":"de Wilde AH, Snijder EJ, Kikkert M, van Hemert MJ. Host factors in coronavirus replication. Curr Top Microbiol Immunol. 2018;419:1\u201342.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"1044_CR32","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","volume":"11","author":"X Lei","year":"2020","unstructured":"Lei X, Dong X, Ma R, Wang W, Xiao X, Tian Z, et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. 2020;11(1):3810.","journal-title":"Nat Commun"},{"issue":"7835","key":"1044_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","volume":"587","author":"D Shin","year":"2020","unstructured":"Shin D, Mukherjee R, Grewe D, Bojkova D, Baek K, Bhattacharya A, et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. 2020;587(7835):657\u201362.","journal-title":"Nature."},{"issue":"13","key":"1044_CR34","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.1128\/JVI.02220-08","volume":"83","author":"M Frieman","year":"2009","unstructured":"Frieman M, Ratia K, Johnston RE, Mesecar AD, Baric RS. Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. J Virol. 2009;83(13):6689\u2013705.","journal-title":"J Virol"},{"issue":"Pt 3","key":"1044_CR35","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1099\/vir.0.059014-0","volume":"95","author":"X Yang","year":"2014","unstructured":"Yang X, Chen X, Bian G, Tu J, Xing Y, Wang Y, et al. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease. J Gen Virol. 2014;95(Pt 3):614\u201326.","journal-title":"J Gen Virol."},{"key":"1044_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.virol.2013.11.040","volume":"450-451","author":"AM Mielech","year":"2014","unstructured":"Mielech AM, Kilianski A, Baez-Santos YM, Mesecar AD, Baker SC. MERS-CoV papain-like protease has deISGylating and deubiquitinating activities. Virology. 2014;450-451:64\u201370.","journal-title":"Virology."},{"issue":"5","key":"1044_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s13238-014-0026-3","volume":"5","author":"X Chen","year":"2014","unstructured":"Chen X, Yang X, Zheng Y, Yang Y, Xing Y, Chen Z. SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex. Protein Cell. 2014;5(5):369\u201381.","journal-title":"Protein Cell"},{"issue":"5","key":"1044_CR38","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/ijms17050678","volume":"17","author":"SW Li","year":"2016","unstructured":"Li SW, Wang CY, Jou YJ, Huang SH, Hsiao LH, Wan L, et al. SARS coronavirus papain-like protease inhibits the TLR7 signaling pathway through removing Lys63-linked Polyubiquitination of TRAF3 and TRAF6. Int J Mol Sci. 2016;17(5):678.","journal-title":"Int J Mol Sci"},{"key":"1044_CR39","doi-asserted-by":"crossref","unstructured":"Knaap RCM, Fern\u00e1ndez-Delgado R, Dalebout TJ, Oreshkova N, Bredenbeek PJ, Enjuanes L, et al. The deubiquitinating activity of Middle East respiratory syndrome coronavirus papain-like protease delays the innate immune response and enhances virulence in a mouse model. bioRxiv. 2019:751578.","DOI":"10.1101\/751578"},{"issue":"8","key":"1044_CR40","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1021\/acsinfecdis.0c00168","volume":"6","author":"BT Freitas","year":"2020","unstructured":"Freitas BT, Durie IA, Murray J, Longo JE, Miller HC, Crich D, et al. Characterization and noncovalent inhibition of the Deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease. ACS Infect Dis. 2020;6(8):2099\u2013109.","journal-title":"ACS Infect Dis"},{"issue":"4","key":"1044_CR41","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1128\/JVI.02514-15","volume":"90","author":"D Wang","year":"2016","unstructured":"Wang D, Fang L, Shi Y, Zhang H, Gao L, Peng G, et al. Porcine epidemic diarrhea virus 3C-like protease regulates its interferon antagonism by cleaving NEMO. J Virol. 2016;90(4):2090\u2013101.","journal-title":"J Virol"},{"key":"1044_CR42","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.virol.2016.12.005","volume":"502","author":"X Zhu","year":"2017","unstructured":"Zhu X, Fang L, Wang D, Yang Y, Chen J, Ye X, et al. Porcine deltacoronavirus nsp5 inhibits interferon-beta production through the cleavage of NEMO. Virology. 2017;502:33\u20138.","journal-title":"Virology."},{"issue":"1","key":"1044_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/v12010043","volume":"12","author":"S Chen","year":"2019","unstructured":"Chen S, Tian J, Li Z, Kang H, Zhang J, Huang J, et al. Feline infectious peritonitis virus Nsp5 inhibits type I interferon production by cleaving NEMO at multiple sites. Viruses. 2019;12(1):43.","journal-title":"Viruses."},{"issue":"10","key":"1044_CR44","doi-asserted-by":"publisher","first-page":"e00003","DOI":"10.1128\/JVI.00003-17","volume":"91","author":"X Zhu","year":"2017","unstructured":"Zhu X, Wang D, Zhou J, Pan T, Chen J, Yang Y, et al. Porcine Deltacoronavirus nsp5 antagonizes type I interferon signaling by cleaving STAT2. J Virol. 2017;91(10):e00003\u201317.","journal-title":"J Virol"},{"issue":"4","key":"1044_CR45","doi-asserted-by":"publisher","first-page":"109892","DOI":"10.1016\/j.celrep.2021.109892","volume":"37","author":"I Pablos","year":"2021","unstructured":"Pablos I, Machado Y, de Jesus HCR, Mohamud Y, Kappelhoff R, Lindskog C, et al. Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CL(pro) substrate degradome. Cell Rep. 2021;37(4):109892.","journal-title":"Cell Rep"},{"issue":"1","key":"1044_CR46","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1038\/s41467-021-25796-w","volume":"12","author":"B Meyer","year":"2021","unstructured":"Meyer B, Chiaravalli J, Gellenoncourt S, Brownridge P, Bryne DP, Daly LA, et al. Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential. Nat Commun. 2021;12(1):5553.","journal-title":"Nat Commun"},{"key":"1044_CR47","doi-asserted-by":"crossref","unstructured":"Yucel N, Marchiano S, Tchelepi E, Paterlini G, McAfee Q, Nimmagadda N, et al. Prediction and validation of host cleavage targets of SARS-CoV-2 3C-like protease. bioRxiv. 2022; 2022.01.17.476677.","DOI":"10.1101\/2022.01.17.476677"},{"key":"1044_CR48","doi-asserted-by":"publisher","first-page":"108234","DOI":"10.1016\/j.celrep.2020.108234","volume":"33","author":"H Xia","year":"2020","unstructured":"Xia H, Cao Z, Xie X, Zhang X, Chen JY, Wang H, et al. Evasion of type I interferon by SARS-CoV-2. Cell Rep. 2020;33:108234.","journal-title":"Cell Rep"},{"issue":"1","key":"1044_CR49","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41392-020-00332-2","volume":"5","author":"Y Wu","year":"2020","unstructured":"Wu Y, Ma L, Zhuang Z, Cai S, Zhao Z, Zhou L, et al. Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling. Signal Transduct Target Ther. 2020;5(1):221.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1044_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-022-00878-3","volume":"7","author":"Y Zheng","year":"2022","unstructured":"Zheng Y, Deng J, Han L, Zhuang MW, Xu Y, Zhang J, et al. SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules. Signal Transduct Target Ther. 2022;7(1):22.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1044_CR51","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/22221751.2020.1870414","volume":"10","author":"M Moustaqil","year":"2021","unstructured":"Moustaqil M, Ollivier E, Chiu HP, Van Tol S, Rudolffi-Soto P, Stevens C, et al. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species. Emerg Microbes Infect. 2021;10(1):178\u201395.","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"1044_CR52","doi-asserted-by":"publisher","first-page":"e0233521","DOI":"10.1128\/mBio.02335-21","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Qin C, Rao Y, Ngo C, Feng JJ, Zhao J, et al. SARS-CoV-2 Nsp5 demonstrates two distinct mechanisms targeting RIG-I and MAVS to evade the innate immune response. mBio. 2021;12(5):e0233521.","journal-title":"mBio."},{"key":"1044_CR53","doi-asserted-by":"crossref","unstructured":"Zhang S, Wang J, Cheng G. Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1. Proc Natl Acad Sci U S A. 2021;118(37).","DOI":"10.1073\/pnas.2107108118"},{"issue":"2","key":"1044_CR54","doi-asserted-by":"publisher","first-page":"e2000246","DOI":"10.1002\/pmic.202000246","volume":"21","author":"T Koudelka","year":"2021","unstructured":"Koudelka T, Boger J, Henkel A, Schonherr R, Krantz S, Fuchs S, et al. N-Terminomics for the identification of in vitro substrates and cleavage site specificity of the SARS-CoV-2 Main protease. Proteomics. 2021;21(2):e2000246.","journal-title":"Proteomics."},{"issue":"7816","key":"1044_CR55","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020;583(7816):459\u201368.","journal-title":"Nature."},{"issue":"7816","key":"1044_CR56","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","volume":"583","author":"D Bojkova","year":"2020","unstructured":"Bojkova D, Klann K, Koch B, Widera M, Krause D, Ciesek S, et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020;583(7816):469\u201372.","journal-title":"Nature."},{"key":"1044_CR57","doi-asserted-by":"crossref","unstructured":"Samavarchi-Tehrani P, Abdouni H, Knight JDR, Astori A, Samson R, Lin Z-Y, et al. A SARS-CoV-2 \u2013 host proximity interactome. bioRxiv. 2020; 2020.09.03.282103.","DOI":"10.1101\/2020.09.03.282103"},{"key":"1044_CR58","doi-asserted-by":"crossref","unstructured":"Laurent EMN, Sofianatos Y, Komarova A, Gimeno J-P, Tehrani PS, Kim D-K, et al. Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms. bioRxiv. 2020; 2020.08.28.272955.","DOI":"10.1101\/2020.08.28.272955"},{"issue":"1","key":"1044_CR59","first-page":"99","volume":"2","author":"J Li","year":"2021","unstructured":"Li J, Guo M, Tian X, Wang X, Yang X, Wu P, et al. Virus-host Interactome and proteomic survey reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. Med (N Y). 2021;2(1):99\u2013112 e7.","journal-title":"Med (N Y)"},{"issue":"6521","key":"1044_CR60","doi-asserted-by":"publisher","first-page":"eabe9403","DOI":"10.1126\/science.abe9403","volume":"370","author":"DE Gordon","year":"2020","unstructured":"Gordon DE, Hiatt J, Bouhaddou M, Rezelj VV, Ulferts S, Braberg H, et al. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science. 2020;370(6521):eabe9403.","journal-title":"Science."},{"key":"1044_CR61","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2105-5-72","volume":"5","author":"L Kiemer","year":"2004","unstructured":"Kiemer L, Lund O, Brunak S, Blom N. Coronavirus 3CLpro proteinase cleavage sites: possible relevance to SARS virus pathology. BMC Bioinformatics. 2004;5:72.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"1044_CR62","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0022-2836(91)90027-4","volume":"220","author":"SJ Hubbard","year":"1991","unstructured":"Hubbard SJ, Campbell SF, Thornton JM. Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. J Mol Biol. 1991;220(2):507\u201330.","journal-title":"J Mol Biol"},{"issue":"8","key":"1044_CR63","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1021\/pr200271w","volume":"10","author":"MD Kazanov","year":"2011","unstructured":"Kazanov MD, Igarashi Y, Eroshkin AM, Cieplak P, Ratnikov B, Zhang Y, et al. Structural determinants of limited proteolysis. J Proteome Res. 2011;10(8):3642\u201351.","journal-title":"J Proteome Res"},{"issue":"3","key":"1044_CR64","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1142\/S021972000500117X","volume":"3","author":"SE Boyd","year":"2005","unstructured":"Boyd SE, Pike RN, Rudy GB, Whisstock JC, Garcia de la Banda M. PoPS: a computational tool for modeling and predicting protease specificity. J Bioinforma Comput Biol. 2005;3(3):551\u201385.","journal-title":"J Bioinforma Comput Biol"},{"issue":"7","key":"1044_CR65","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.tibs.2009.04.001","volume":"34","author":"J Verspurten","year":"2009","unstructured":"Verspurten J, Gevaert K, Declercq W, Vandenabeele P. SitePredicting the cleavage of proteinase substrates. Trends Biochem Sci. 2009;34(7):319\u201323.","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"1044_CR66","doi-asserted-by":"publisher","first-page":"e50300","DOI":"10.1371\/journal.pone.0050300","volume":"7","author":"J Song","year":"2012","unstructured":"Song J, Tan H, Perry AJ, Akutsu T, Webb GI, Whisstock JC, et al. PROSPER: an integrated feature-based tool for predicting protease substrate cleavage sites. PLoS One. 2012;7(11):e50300.","journal-title":"PLoS One"},{"issue":"46","key":"1044_CR67","doi-asserted-by":"publisher","first-page":"12997","DOI":"10.1073\/pnas.1601327113","volume":"113","author":"T Muramatsu","year":"2016","unstructured":"Muramatsu T, Takemoto C, Kim YT, Wang H, Nishii W, Terada T, et al. SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity. Proc Natl Acad Sci U S A. 2016;113(46):12997\u20133002.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1044_CR68","doi-asserted-by":"crossref","unstructured":"Peng K, Obradovic Z, Vucetic S. Exploring bias in the protein data Bank using contrast classifiers. Pac Symp Biocomput. 2004:435\u201346.","DOI":"10.1142\/9789812704856_0041"},{"issue":"3","key":"1044_CR69","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0022-2836(71)90324-X","volume":"55","author":"B Lee","year":"1971","unstructured":"Lee B, Richards FM. The interpretation of protein structures: estimation of static accessibility. J Mol Biol. 1971;55(3):379\u2013400.","journal-title":"J Mol Biol"},{"key":"1044_CR70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1472-6807-8-21","volume":"8","author":"J Mihel","year":"2008","unstructured":"Mihel J, Sikic M, Tomic S, Jeren B, Vlahovicek K. PSAIA - protein structure and interaction analyzer. BMC Struct Biol. 2008;8:21.","journal-title":"BMC Struct Biol"},{"issue":"2","key":"1044_CR71","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","volume":"18","author":"NT Doncheva","year":"2019","unstructured":"Doncheva NT, Morris JH, Gorodkin J, Jensen LJ. Cytoscape StringApp: network analysis and visualization of proteomics data. J Proteome Res. 2019;18(2):623\u201332.","journal-title":"J Proteome Res"},{"issue":"11","key":"1044_CR72","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"1","key":"1044_CR73","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/0471250953.bi0813s47","volume":"47","author":"G Su","year":"2014","unstructured":"Su G, Morris JH, Demchak B, Bader GD. Biological network exploration with Cytoscape 3. Curr Protoc Bioinformatics. 2014;47(1):8\u201313.","journal-title":"Curr Protoc Bioinformatics"},{"issue":"24","key":"1044_CR74","doi-asserted-by":"publisher","first-page":"12392","DOI":"10.1128\/JVI.01219-08","volume":"82","author":"M Oostra","year":"2008","unstructured":"Oostra M, Hagemeijer MC, van Gent M, Bekker CP, te Lintelo EG, Rottier PJ, et al. Topology and membrane anchoring of the coronavirus replication complex: not all hydrophobic domains of nsp3 and nsp6 are membrane spanning. J Virol. 2008;82(24):12392\u2013405.","journal-title":"J Virol"},{"issue":"12","key":"1044_CR75","doi-asserted-by":"publisher","first-page":"5927","DOI":"10.1128\/JVI.02501-05","volume":"80","author":"EJ Snijder","year":"2006","unstructured":"Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J, Onderwater JJ, van der Meulen J, Koerten HK, et al. Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol. 2006;80(12):5927\u201340.","journal-title":"J Virol"},{"issue":"9","key":"1044_CR76","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1371\/journal.pbio.0060226","volume":"6","author":"K Knoops","year":"2008","unstructured":"Knoops K, Kikkert M, Worm SH, Zevenhoven-Dobbe JC, van der Meer Y, Koster AJ, et al. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol. 2008;6(9):e226.","journal-title":"PLoS Biol"},{"issue":"1","key":"1044_CR77","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41392-020-00372-8","volume":"5","author":"J Zhang","year":"2020","unstructured":"Zhang J, Cruz-Cosme R, Zhuang MW, Liu D, Liu Y, Teng S, et al. A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins. Signal Transduct Target Ther. 2020;5(1):269.","journal-title":"Signal Transduct Target Ther."},{"key":"1044_CR78","doi-asserted-by":"crossref","unstructured":"Thul PJ, Akesson L, Wiking M, Mahdessian D, Geladaki A, Ait Blal H, et al. A subcellular map of the human proteome. Science. 2017;356(6340).","DOI":"10.1126\/science.aal3321"},{"issue":"4","key":"1044_CR79","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/nar\/gkv1376","volume":"44","author":"AA Riccio","year":"2016","unstructured":"Riccio AA, Cingolani G, Pascal JM. PARP-2 domain requirements for DNA damage-dependent activation and localization to sites of DNA damage. Nucleic Acids Res. 2016;44(4):1691\u2013702.","journal-title":"Nucleic Acids Res"},{"key":"1044_CR80","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3389\/fimmu.2017.01801","volume":"8","author":"D Liang","year":"2017","unstructured":"Liang D, Tian L, You R, Halpert MM, Konduri V, Baig YC, et al. AIMp1 potentiates TH1 polarization and is critical for effective antitumor and antiviral immunity. Front Immunol. 2017;8:1801.","journal-title":"Front Immunol"},{"issue":"5","key":"1044_CR81","doi-asserted-by":"publisher","first-page":"e96302","DOI":"10.1371\/journal.pone.0096302","volume":"9","author":"MS Kim","year":"2014","unstructured":"Kim MS, Kim S, Myung H. Degradation of AIMP1\/p43 induced by hepatitis C virus E2 leads to upregulation of TGF-beta signaling and increase in surface expression of gp96. PLoS One. 2014;9(5):e96302.","journal-title":"PLoS One"},{"issue":"3","key":"1044_CR82","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","volume":"182","author":"M Bouhaddou","year":"2020","unstructured":"Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, Correa Marrero M, et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell. 2020;182(3):685\u2013712 e19.","journal-title":"Cell."},{"key":"1044_CR83","doi-asserted-by":"crossref","unstructured":"Spalinger MR, Hai R, Li J, Santos AN, Nordgren TM, Tremblay ML, et al. Identification of a novel susceptibility marker for SARS-CoV-2 infection in human subjects and risk mitigation with a clinically approved JAK inhibitor in human\/mouse cells. bioRxiv. 2020.","DOI":"10.1101\/2020.12.09.416586"},{"issue":"5","key":"1044_CR84","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.cell.2020.10.004","volume":"183","author":"AK Banerjee","year":"2020","unstructured":"Banerjee AK, Blanco MR, Bruce EA, Honson DD, Chen LM, Chow A, et al. SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell. 2020;183(5):1325\u201339 e21.","journal-title":"Cell."},{"issue":"7862","key":"1044_CR85","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-021-03610-3","volume":"594","author":"Y Finkel","year":"2021","unstructured":"Finkel Y, Gluck A, Nachshon A, Winkler R, Fisher T, Rozman B, et al. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis. Nature. 2021;594(7862):240\u20135.","journal-title":"Nature."},{"issue":"1","key":"1044_CR86","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ncb2000","volume":"12","author":"M Ostrowski","year":"2010","unstructured":"Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010;12(1):19\u201330.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"1044_CR87","doi-asserted-by":"publisher","first-page":"100940","DOI":"10.1016\/j.jbc.2021.100940","volume":"297","author":"JM Hutchison","year":"2021","unstructured":"Hutchison JM, Capone R, Luu DD, Shah KH, Hadziselimovic A, Van Horn WD, et al. Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells. J Biol Chem. 2021;297(2):100940.","journal-title":"J Biol Chem"},{"issue":"4","key":"1044_CR88","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1600-0854.2009.01029.x","volume":"11","author":"JL Johnson","year":"2010","unstructured":"Johnson JL, Brzezinska AA, Tolmachova T, Munafo DB, Ellis BA, Seabra MC, et al. Rab27a and Rab27b regulate neutrophil azurophilic granule exocytosis and NADPH oxidase activity by independent mechanisms. Traffic. 2010;11(4):533\u201347.","journal-title":"Traffic."},{"issue":"40","key":"1044_CR89","doi-asserted-by":"publisher","first-page":"20063","DOI":"10.1073\/pnas.1906431116","volume":"116","author":"T Xia","year":"2019","unstructured":"Xia T, Yi XM, Wu X, Shang J, Shu HB. PTPN1\/2-mediated dephosphorylation of MITA\/STING promotes its 20S proteasomal degradation and attenuates innate antiviral response. Proc Natl Acad Sci U S A. 2019;116(40):20063\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1044_CR90","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.leukres.2013.05.008","volume":"37","author":"Y Nishiyama-Fujita","year":"2013","unstructured":"Nishiyama-Fujita Y, Shimizu T, Sagawa M, Uchida H, Kizaki M. The role of TC-PTP (PTPN2) in modulating sensitivity to imatinib and interferon-alpha in CML cell line, KT-1 cells. Leuk Res. 2013;37(9):1150\u20135.","journal-title":"Leuk Res"},{"issue":"9","key":"1044_CR91","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1182\/blood-2003-09-3153","volume":"103","author":"KM Heinonen","year":"2004","unstructured":"Heinonen KM, Nestel FP, Newell EW, Charette G, Seemayer TA, Tremblay ML, et al. T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood. 2004;103(9):3457\u201364.","journal-title":"Blood."},{"issue":"2","key":"1044_CR92","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/v12020181","volume":"12","author":"F Taschuk","year":"2020","unstructured":"Taschuk F, Cherry S. DEAD-box helicases: sensors, regulators, and effectors for antiviral defense. Viruses. 2020;12(2):181.","journal-title":"Viruses."},{"issue":"6262","key":"1044_CR93","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1126\/science.aab3145","volume":"350","author":"P Wang","year":"2015","unstructured":"Wang P, Zhu S, Yang L, Cui S, Pan W, Jackson R, et al. Nlrp6 regulates intestinal antiviral innate immunity. Science. 2015;350(6262):826\u201330.","journal-title":"Science."},{"issue":"323","key":"1044_CR94","doi-asserted-by":"publisher","first-page":"ra40","DOI":"10.1126\/scisignal.2004841","volume":"7","author":"K Mosallanejad","year":"2014","unstructured":"Mosallanejad K, Sekine Y, Ishikura-Kinoshita S, Kumagai K, Nagano T, Matsuzawa A, et al. The DEAH-box RNA helicase DHX15 activates NF-kappaB and MAPK signaling downstream of MAVS during antiviral responses. Sci Signal. 2014;7(323):ra40.","journal-title":"Sci Signal"},{"issue":"6","key":"1044_CR95","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1089\/jir.2018.0163","volume":"39","author":"S Pattabhi","year":"2019","unstructured":"Pattabhi S, Knoll ML, Gale M Jr, Loo YM. DHX15 is a Coreceptor for RLR signaling that promotes antiviral defense against RNA virus infection. J Interf Cytokine Res. 2019;39(6):331\u201346.","journal-title":"J Interf Cytokine Res"},{"key":"1044_CR96","doi-asserted-by":"crossref","unstructured":"Wang Y, Wu X, Ge R, Song L, Li K, Tian S, et al. Global Screening of Sentrin-Specific Protease Family Substrates in SUMOylation. bioRxiv. 2020; 2020.02.25.964072.","DOI":"10.1101\/2020.02.25.964072"},{"issue":"8","key":"1044_CR97","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1128\/JVI.00031-13","volume":"87","author":"L Wang","year":"2013","unstructured":"Wang L, Zhao W, Zhang M, Wang P, Zhao K, Zhao X, et al. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. J Virol. 2013;87(8):4507\u201315.","journal-title":"J Virol"},{"issue":"6330","key":"1044_CR98","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","volume":"355","author":"CJ Lord","year":"2017","unstructured":"Lord CJ, Ashworth A. PARP inhibitors: synthetic lethality in the clinic. Science. 2017;355(6330):1152\u20138.","journal-title":"Science."},{"issue":"18","key":"1044_CR99","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1038\/sj.emboj.7601301","volume":"25","author":"J Yelamos","year":"2006","unstructured":"Yelamos J, Monreal Y, Saenz L, Aguado E, Schreiber V, Mota R, et al. PARP-2 deficiency affects the survival of CD4+CD8+ double-positive thymocytes. EMBO J. 2006;25(18):4350\u201360.","journal-title":"EMBO J"},{"key":"1044_CR100","doi-asserted-by":"publisher","first-page":"34487","DOI":"10.1038\/srep34487","volume":"6","author":"E Obaji","year":"2016","unstructured":"Obaji E, Haikarainen T, Lehtio L. Characterization of the DNA dependent activation of human ARTD2\/PARP2. Sci Rep. 2016;6:34487.","journal-title":"Sci Rep"},{"issue":"37","key":"1044_CR101","doi-asserted-by":"publisher","first-page":"34217","DOI":"10.1074\/jbc.M203941200","volume":"277","author":"A Benchoua","year":"2002","unstructured":"Benchoua A, Couriaud C, Guegan C, Tartier L, Couvert P, Friocourt G, et al. Active caspase-8 translocates into the nucleus of apoptotic cells to inactivate poly(ADP-ribose) polymerase-2. J Biol Chem. 2002;277(37):34217\u201322.","journal-title":"J Biol Chem"},{"issue":"1","key":"1044_CR102","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41392-020-00334-0","volume":"5","author":"S Li","year":"2020","unstructured":"Li S, Zhang Y, Guan Z, Li H, Ye M, Chen X, et al. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation. Signal Transduct Target Ther. 2020;5(1):235.","journal-title":"Signal Transduct Target Ther."},{"issue":"3","key":"1044_CR103","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1574-695X.2006.00045.x","volume":"46","author":"CW Lin","year":"2006","unstructured":"Lin CW, Lin KH, Hsieh TH, Shiu SY, Li JY. Severe acute respiratory syndrome coronavirus 3C-like protease-induced apoptosis. FEMS Immunol Med Microbiol. 2006;46(3):375\u201380.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1044_CR104","doi-asserted-by":"crossref","unstructured":"Prescott L. SARS-CoV-2 3CLpro whole human proteome cleavage prediction and enrichment\/depletion analysis. bioRxiv. 2020; 2020.08.24.265645.","DOI":"10.1101\/2020.08.24.265645"},{"issue":"D1","key":"1044_CR105","doi-asserted-by":"publisher","first-page":"D313","DOI":"10.1093\/nar\/gkw1132","volume":"45","author":"S Bienert","year":"2017","unstructured":"Bienert S, Waterhouse A, de Beer TA, Tauriello G, Studer G, Bordoli L, et al. The SWISS-MODEL repository-new features and functionality. Nucleic Acids Res. 2017;45(D1):D313\u2013D9.","journal-title":"Nucleic Acids Res"},{"key":"1044_CR106","volume-title":"R: A language and environment for statistical computing Vienna, Austria","author":"R Core Team","year":"2020","unstructured":"R Core Team. R: A language and environment for statistical computing Vienna, Austria. 2020. Available from: https:\/\/www.R-project.org\/."},{"issue":"43","key":"1044_CR107","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham H, Averick M, Bryan J, Chang W, McGowan LD, Fran\u00e7ois R, et al. Welcome to the Tidyverse. J Open Source Softw. 2019;4(43):1686.","journal-title":"J Open Source Softw"},{"key":"1044_CR108","volume-title":"ggrepel: Automatically Position Non-Overlapping Text Labels with 'ggplot2'. R package version 0.8.2","author":"K Slowikowski","year":"2020","unstructured":"Slowikowski K. ggrepel: Automatically Position Non-Overlapping Text Labels with 'ggplot2'. R package version 0.8.2. 2020. Available from: https:\/\/CRAN.R-project.org\/package=ggrepel."},{"issue":"6220","key":"1044_CR109","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.","journal-title":"Science."}],"container-title":["BMC Genomic Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12863-022-01044-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12863-022-01044-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12863-022-01044-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T10:34:40Z","timestamp":1726914880000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenet.biomedcentral.com\/articles\/10.1186\/s12863-022-01044-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,4]]},"references-count":109,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1186\/s12863-022-01044-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.08.447224","asserted-by":"object"}]},"ISSN":["2730-6844"],"issn-type":[{"value":"2730-6844","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,4]]},"assertion":[{"value":"16 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}